marketcaparena

SNOA

Sonoma Pharmaceuticals, Inc.

Company overview

Market capitalization
$6.03M
Employees
10
Latest publication
2026-09-29
About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ2 20252024-09-30 · USDQ3 20242023-12-31 · USDQ2 20232022-09-30 · USDQ1 20232022-06-30 · USD
Total Revenue5,561,000USD4,349,000USD5,604,000USD3,754,000USD3,579,000USD3,138,000USD3,331,000USD3,983,000USD
Cost Of Revenue3,380,000USD2,699,000USD3,484,000USD2,226,000USD2,218,000USD1,678,000USD1,795,000USD2,337,000USD
Gross Profit2,181,000USD1,650,000USD2,120,000USD1,528,000USD1,361,000USD1,460,000USD1,536,000USD1,646,000USD
Research Development545,000USD557,000USD575,000USD411,000USD506,000USD601,000USD200,000USD206,000USD
Selling General Administrative1,987,000USD1,771,000USD1,882,000USD1,773,000USD1,705,000USD1,703,000USD2,067,000USD3,066,000USD
Total Operating Expenses2,532,000USD2,328,000USD2,457,000USD2,184,000USD2,211,000USD2,304,000USD2,267,000USD2,501,000USD
Operating Income-351,000USD-678,000USD-337,000USD-656,000USD-850,000USD-844,000USD-731,000USD-855,000USD
Income Before Tax-497,000USD-949,000USD-731,000USD-528,000USD-463,000USD-923,000USD-917,000USD-922,000USD
Income Tax Expense84,000USD-130,000USD-197,000USD248,000USD147,000USD-57,000USD100,000USD-35,000USD
Tax Provision84,000USD-130,000USD-197,000USD248,000USD147,000USD-57,000USD100,000USD-35,000USD
Net Income-581,000USD-819,000USD-534,000USD-776,000USD-610,000USD-866,000USD-1,017,000USD-887,000USD
Net Income From Continuing Ops-581,000USD-819,000USD-534,000USD-776,000USD-610,000USD-866,000USD-1,017,000USD-887,000USD
Ebit-351,000USD-678,000USD-337,000USD-656,000USD-850,000USD-923,000USD-917,000USD-922,000USD
Ebitda-318,000USD-644,000USD-301,000USD-625,000USD-815,000USD-878,000USD-889,000USD-891,000USD
Depreciation And Amortization33,000USD34,000USD36,000USD31,000USD35,000USD45,000USD28,000USD31,000USD
Reconciled Depreciation33,000USD34,000USD36,000USD31,000USD35,000USD45,000USD28,000USD31,000USD
Total Other Income Expense Net-146,000USD-271,000USD-394,000USD128,000USD387,000USD-79,000USD-186,000USD-67,000USD
Interest Expense——————3,000USD9,000USD
Net Interest Income——————3,000USD0USD
Net Income Applicable To Common Shares——————-1,017,000USD-887,000USD
Selling And Marketing Expenses———————86,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20042004-03-31 · USDFY 20022002-03-31 · USD
Total Revenue902,000USD2,000,000USD
Gross Profit902,000USD1,185,000USD
Other Operating Expenses902,000USD—
Total Operating Expenses902,000USD1,332,000USD
Operating Income902,000USD-147,000USD
Interest Expense0USD0USD
Income Tax Expense8,040,000USD24,000USD
Net Income-7,298,000USD-167,000USD
Ebit902,000USD-147,000USD
Ebitda1,062,000USD-147,000USD
Depreciation And Amortization160,000USD-4,000USD
Total Other Income Expense Net-902,000USD147,000USD
Cost Of Revenue—815,000USD
Research Development—6,000USD
Selling General Administrative—1,326,000USD
Income Before Tax—-143,000USD
SourceLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20272026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
Total Assets18,107,000USD13,960,000USD13,623,000USD13,856,000USD14,594,000USD13,693,000USD13,668,000USD13,685,000USD
Cash And Equivalents5,338,000USD———————
Total Current Assets16,268,000USD12,100,000USD12,145,000USD12,501,000USD13,107,000USD12,648,000USD12,380,000USD12,221,000USD
Other Current Assets3,962,000USD615,000USD3,499,000USD3,129,000USD3,098,000USD596,000USD1,596,000USD2,149,000USD
Other Non Current Assets66,000USD———————
Total Liabilities11,513,000USD———————
Total Current Liabilities5,447,000USD4,832,000USD4,217,000USD4,322,000USD4,848,000USD4,096,000USD3,703,000USD3,309,000USD
Total Stockholder Equity6,594,000USD3,095,000USD3,432,000USD3,787,000USD4,056,000USD4,411,000USD4,870,000USD5,352,000USD
Total Equity Including Noncontrolling Interest6,594,000USD———————
Deferred Revenue282,000USD———————
Net Receivables3,182,000USD5,435,000USD2,382,000USD2,703,000USD2,602,000USD3,763,000USD2,405,000USD3,157,000USD
Inventory3,786,000USD3,651,000USD3,703,000USD3,634,000USD3,802,000USD2,915,000USD3,143,000USD2,837,000USD
Property Plant Equipment Net868,000USD912,000USD956,000USD763,000USD837,000USD309,000USD334,000USD417,000USD
Accounts Payable2,191,000USD1,923,000USD1,646,000USD1,404,000USD2,046,000USD953,000USD1,395,000USD770,000USD
Short Term Debt160,000USD373,000USD146,000USD144,000USD235,000USD278,000USD90,000USD198,000USD
Common Stock0USD———————
Retained Earnings-201,311,000USD-200,981,000USD-200,400,000USD-199,581,000USD-199,047,000USD-197,806,000USD-197,030,000USD-196,102,000USD
Accumulated Other Comprehensive Income-3,008,000USD-3,242,999USD-3,191,000USD-3,365,000USD-3,569,999USD-4,375,999USD-4,554,000USD-4,197,000USD
Total Liab—10,865,000USD10,191,000USD10,069,000USD10,538,000USD9,282,000USD8,798,000USD8,333,000USD
Other Current Liab—-3,312,000USD-3,354,000USD-3,332,000USD-3,410,000USD2,224,000USD-3,120,000USD-2,911,000USD
Capital Stock—0USD0USD0USD0USD0USD0USD0USD
Cash—2,399,000USD2,561,000USD3,035,000USD3,605,000USD5,374,000USD5,236,000USD4,078,000USD
Cash And Short Term Investments—2,399,000USD2,561,000USD3,035,000USD3,605,000USD5,374,000USD5,236,000USD4,078,000USD
Current Deferred Revenue—284,000USD314,000USD750,000USD731,000USD641,000USD302,000USD319,000USD
Net Debt—-1,557,000USD-1,906,000USD-2,500,000USD-2,930,000USD-5,069,000USD-5,117,000USD-3,834,000USD
Short Long Term Debt—222,000USD—56,000USD139,000USD220,000USD—82,000USD
Short Long Term Debt Total—842,000USD655,000USD535,000USD675,000USD305,000USD119,000USD244,000USD
Property Plant Equipment Gross—3,392,000USD956,000USD763,000USD837,000USD2,384,000USD334,000USD417,000USD
Common Stock Shares Outstanding—1,764,331shares1,713,000shares1,646,000shares1,641,000shares1,241,000shares1,464,000shares1,034,000shares
Non Current Assets Total—1,860,000USD1,478,000USD1,355,000USD1,487,000USD1,045,000USD1,288,000USD1,464,000USD
Non Current Liabilities Total—6,033,000USD5,974,000USD5,747,000USD5,690,000USD5,186,000USD5,095,000USD5,024,000USD
Non Currrent Assets Other—64,000USD64,000USD84,000USD104,000USD147,000USD194,000USD255,000USD
Net Working Capital—7,268,000USD7,928,000USD8,179,000USD8,259,000USD8,552,000USD8,677,000USD8,912,000USD
Unclassified Current Liabilities—2,030,000USD2,111,000USD1,968,000USD1,697,000USD—1,916,000USD1,940,000USD
Unclassified Non Current Liabilities—6,033,000USD5,974,000USD5,747,000USD5,690,000USD5,186,000USD5,095,000USD5,024,000USD
Unclassified Equity—207,318,999USD207,023,000USD206,733,000USD206,672,999USD206,592,999USD206,454,000USD205,651,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
Total Assets13,960,000USD13,693,000USD14,740,000USD16,231,000USD18,845,000USD14,987,000USD14,561,000USD14,448,000USD
Other Current Assets615,000USD596,000USD707,000USD4,548,000USD3,964,000USD3,427,000USD2,527,000USD1,917,000USD
Total Liab10,865,000USD9,282,000USD8,603,000USD8,254,000USD10,148,000USD9,624,000USD8,937,000USD3,959,000USD
Total Stockholder Equity3,095,000USD4,411,000USD6,137,000USD7,977,000USD8,697,000USD5,363,000USD5,624,000USD10,489,000USD
Other Current Liab-3,312,000USD2,224,000USD-2,597,000USD-2,206,000USD-1,995,000USD-2,324,000USD1,774,000USD1,771,000USD
Capital Stock0USD0USD2,000USD5,000USD2,000USD2,000USD2,000USD2,000USD
Retained Earnings-200,981,000USD-197,806,000USD-194,349,000USD-189,514,000USD-184,363,000USD-179,277,000USD-175,327,000USD-169,238,000USD
Cash2,399,000USD5,374,000USD3,128,000USD3,820,000USD7,396,000USD4,220,000USD3,691,000USD3,689,000USD
Cash And Short Term Investments2,399,000USD5,374,000USD3,128,000USD3,820,000USD7,396,000USD4,220,000USD3,691,000USD3,689,000USD
Total Current Assets12,100,000USD12,648,000USD12,548,000USD13,798,000USD16,430,000USD12,983,000USD12,383,000USD12,496,000USD
Total Current Liabilities4,832,000USD4,096,000USD3,719,000USD3,717,000USD5,819,000USD4,078,000USD4,729,000USD3,591,000USD
Current Deferred Revenue284,000USD641,000USD478,000USD160,000USD1,277,000USD319,000USD273,000USD102,000USD
Net Debt-1,557,000USD-5,069,000USD-2,520,000USD-2,971,000USD-6,029,000USD-1,545,000USD-2,841,000USD-3,214,000USD
Short Term Debt373,000USD278,000USD521,000USD687,000USD1,058,000USD836,000USD615,000USD463,000USD
Short Long Term Debt222,000USD220,000USD323,000USD431,000USD808,000USD596,000USD481,000USD322,000USD
Short Long Term Debt Total842,000USD305,000USD608,000USD849,000USD1,367,000USD2,675,000USD850,000USD475,000USD
Net Receivables5,435,000USD3,763,000USD5,994,000USD2,572,000USD2,407,000USD2,806,000USD3,973,000USD3,481,000USD
Inventory3,651,000USD2,915,000USD2,719,000USD2,858,000USD2,663,000USD2,530,000USD2,192,000USD3,409,000USD
Accounts Payable1,923,000USD953,000USD607,000USD841,000USD1,641,000USD1,769,000USD2,067,000USD1,255,000USD
Property Plant Equipment Net912,000USD309,000USD651,000USD906,000USD879,000USD1,129,000USD1,328,000USD727,000USD
Property Plant Equipment Gross3,392,000USD2,384,000USD3,031,000USD2,920,000USD2,590,000USD1,129,000USD1,328,000USD727,000USD
Accumulated Other Comprehensive Income-3,242,999USD-4,375,999USD-2,723,000USD-3,418,000USD-4,312,000USD-4,579,000USD-5,610,000USD-4,349,000USD
Common Stock Shares Outstanding1,684,000shares1,241,000shares909,000shares339,400shares265,300shares199,600shares147,700shares92,398shares
Non Current Assets Total1,860,000USD1,045,000USD2,192,000USD2,433,000USD2,415,000USD2,004,000USD2,178,000USD1,952,000USD
Non Current Liabilities Total6,033,000USD5,186,000USD4,884,000USD4,537,000USD4,329,000USD5,546,000USD4,208,000USD368,000USD
Non Currrent Assets Other64,000USD147,000USD396,000USD578,000USD707,000USD875,000USD850,000USD1,225,000USD
Net Working Capital7,268,000USD8,552,000USD8,829,000USD10,081,000USD10,611,000USD8,905,000USD7,518,000USD8,905,000USD
Unclassified Current Liabilities2,030,000USD—1,790,000USD1,598,000USD1,035,000USD———
Unclassified Non Current Liabilities6,033,000USD5,186,000USD4,884,000USD——-3,707,000USD2,972,000USD—
Unclassified Equity207,318,999USD206,592,999USD203,205,000USD200,899,000USD197,368,000USD189,215,000USD186,557,000USD184,072,000USD
Common Stock——2,000USD5,000USD2,000USD2,000USD2,000USD2,000USD
Unclassified Non Current Assets——1,145,000USD————-1,225,000USD
Other Liab———4,375,000USD4,020,000USD3,707,000USD245,000USD356,000USD
Other Assets———1,527,000USD1,536,000USD875,000USD850,000USD1,225,000USD
Net Tangible Assets———7,977,000USD8,697,000USD5,363,000USD8,705,000USD10,489,000USD
Deferred Long Term Liab—————229,000USD245,000USD356,000USD
Long Term Debt—————1,310,000USD—12,000USD
Non Current Liabilities Other—————4,007,000USD746,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20272026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
Net Income-330,000USD-581,000USD-577,000USD-776,000USD-1,241,000USD-928,000USD-610,000USD-610,000USD
Depreciation32,000USD33,000USD39,000USD31,000USD36,000USD33,000USD35,000USD35,000USD
Stock Based Compensation58,000USD135,000USD-27,000USD90,000USD57,000USD13,000USD14,000USD14,000USD
Unclassified Operating Cash Flow282,000USD———————
Change To Account Receivables-650,000USD-168,000USD340,000USD215,000USD-216,000USD646,000USD43,000USD43,000USD
Change To Inventory-81,000USD19,000USD-40,000USD291,000USD-652,000USD-309,000USD-256,000USD-256,000USD
Change In Working Capital-691,000USD840,000USD99,000USD198,000USD-512,000USD1,466,000USD904,000USD904,000USD
Operating Cash Flow-649,000USD———————
Capital Expenditures-2,000USD-29,000USD-47,000USD-47,000USD-106,000USD-2,000USD-26,000USD-26,000USD
Investing Cash Flow-2,000USD———————
Financing Cash Flow3,454,000USD———————
Effect Of Forex Changes On Cash136,000USD———————
Change In Cash2,939,000USD-162,000USD-474,000USD138,000USD-1,769,000USD1,158,000USD1,489,000USD1,489,000USD
End Cash Flow5,338,000USD———————
Other Non Cash Items—-515,000USD-217,000USD174,000USD-448,000USD174,000USD-55,000USD-55,000USD
Total Cash From Operating Activities—-519,000USD-764,000USD-95,000USD-2,015,000USD565,000USD354,000USD354,000USD
Free Cash Flow—-548,000USD-811,000USD-142,000USD-2,121,000USD563,000USD328,000USD328,000USD
Total Cashflows From Investing Activities—-29,000USD-47,000USD-47,000USD-106,000USD-2,000USD-26,000USD-26,000USD
Net Borrowings—-51,000USD-56,000USD-83,000USD-81,000USD-81,000USD-82,000USD-122,000USD
Total Cash From Financing Activities—387,000USD210,000USD242,000USD-58,000USD708,000USD1,444,000USD1,444,000USD
Sale Purchase Of Stock—0USD———0USD——
Issuance Of Capital Stock—161,000USD266,000USD0USD0USD0USD790,000USD1,541,000USD
Begin Period Cash Flow—2,561,000USD3,035,000USD5,236,000USD5,374,000USD4,078,000USD2,589,000USD2,589,000USD
End Period Cash Flow—2,399,000USD2,561,000USD5,374,000USD3,605,000USD5,236,000USD4,078,000USD4,078,000USD
Other Cashflows From Investing Activities—37,000USD-37,000USD—————
Other Cashflows From Financing Activities—277,000USD-94,000USD302,000USD—1,000USD25,000USD25,000USD
Investments———-10,000USD-106,000USD-47,000USD-2,000USD-26,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
Net Income-3,175,000USD-3,457,000USD-4,835,000USD-5,151,000USD-5,086,000USD-3,950,000USD-3,308,000USD-11,798,000USD
Depreciation139,000USD138,000USD176,000USD125,000USD186,000USD227,000USD312,000USD453,000USD
Stock Based Compensation255,000USD224,000USD516,000USD669,000USD382,000USD371,000USD839,000USD1,635,000USD
Other Non Cash Items-515,000USD174,000USD161,000USD106,000USD-2,032,000USD4,000USD-773,000USD-741,000USD
Change To Account Receivables-122,000USD434,000USD-230,000USD62,000USD1,971,000USD2,608,000USD-2,190,000USD-1,164,000USD
Change To Inventory-465,000USD-388,000USD184,000USD44,000USD-100,000USD-65,000USD323,000USD-779,000USD
Change In Working Capital-406,000USD2,476,000USD1,693,000USD-1,864,000USD3,131,000USD1,384,000USD-1,661,000USD-1,266,000USD
Total Cash From Operating Activities-3,933,000USD-88,000USD-2,398,000USD-6,152,000USD-4,248,000USD-3,378,000USD-4,591,000USD-11,717,000USD
Capital Expenditures-192,000USD-80,000USD-17,000USD-269,000USD-137,000USD-179,000USD-206,000USD-100,000USD
Free Cash Flow-4,125,000USD-168,000USD-2,415,000USD-6,421,000USD-4,385,000USD-3,557,000USD-4,797,000USD-11,817,000USD
Total Cashflows From Investing Activities-192,000USD-80,000USD-2,000USD-258,000USD-99,000USD388,000USD3,644,000USD-131,000USD
Net Borrowings-271,000USD-404,000USD-481,000USD-379,000USD-374,000USD1,021,000USD-347,000USD-478,000USD
Total Cash From Financing Activities477,000USD3,030,000USD1,676,000USD2,489,000USD7,396,000USD3,308,000USD1,029,000USD5,492,000USD
Sale Purchase Of Stock0USD-1,000USD0USD——3,597,000USD1,376,000USD5,970,000USD
Issuance Of Capital Stock427,000USD3,079,000USD1,784,000USD2,868,000USD7,554,000USD6,892,000USD1,376,000USD5,970,000USD
Change In Cash-2,975,000USD2,246,000USD-692,000USD-3,576,000USD3,176,000USD529,000USD2,000USD-6,377,000USD
Begin Period Cash Flow5,374,000USD3,128,000USD3,820,000USD7,396,000USD4,220,000USD3,691,000USD3,689,000USD10,066,000USD
End Period Cash Flow2,399,000USD5,374,000USD3,128,000USD3,820,000USD7,396,000USD4,220,000USD3,691,000USD3,689,000USD
Other Cashflows From Financing Activities277,000USD356,000USD373,000USD515,000USD216,000USD388,000USD1,376,000USD270,000USD
Investments—-80,000USD-2,000USD-258,000USD-99,000USD388,000USD3,644,000USD-131,000USD
Unclassified Financing Cash Flow—3,079,000USD1,784,000USD——-1,698,000USD-1,376,000USD—
Other Cashflows From Investing Activities——15,000USD11,000USD38,000USD567,000USD1,150,000USD-31,000USD
Change To Liabilities———-2,160,000USD743,000USD-811,000USD177,000USD-32,000USD
Exchange Rate Changes—————211,000USD-80,000USD-21,000USD
Cash And Cash Equivalents Changes—————529,000USD2,000USD-6,377,000USD
Unclassified Operating Cash Flow—————-1,414,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30GeographyAsia910,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyEurope1,964,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyLatin America626,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyRest of World480,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyUnited States2,426,000USDDisclosure
Q4 2026Quarterly · 2026-03-31GeographyAsia381,000USDLegacy provider
Q4 2026Quarterly · 2026-03-31GeographyEurope1,725,000USDLegacy provider
Q4 2026Quarterly · 2026-03-31GeographyLatin America759,000USDLegacy provider
Q4 2026Quarterly · 2026-03-31GeographyRest of World694,000USDLegacy provider
Q4 2026Quarterly · 2026-03-31GeographyUnited States2,002,000USDLegacy provider
FY 2026Yearly · 2026-03-31GeographyAsia2,900,000USD0001683168-26-004871
FY 2026Yearly · 2026-03-31GeographyEurope6,904,000USD0001683168-26-004871
FY 2026Yearly · 2026-03-31GeographyLatin America2,373,000USD0001683168-26-004871
FY 2026Yearly · 2026-03-31GeographyRest of World1,678,000USD0001683168-26-004871
FY 2026Yearly · 2026-03-31GeographyUnited States5,674,000USD0001683168-26-004871
Q3 2026Quarterly · 2025-12-31GeographyAsia800,000USD0001683168-26-000889
Q3 2026Quarterly · 2025-12-31GeographyEurope1,560,000USD0001683168-26-000889
Q3 2026Quarterly · 2025-12-31GeographyLatin America518,000USD0001683168-26-000889
Q3 2026Quarterly · 2025-12-31GeographyRest of World253,000USD0001683168-26-000889
Q3 2026Quarterly · 2025-12-31GeographyUnited States1,218,000USD0001683168-26-000889
Q1 2026Quarterly · 2025-06-30GeographyAsia662,000USD0001683168-25-005753
Q1 2026Quarterly · 2025-06-30GeographyEurope1,468,000USD0001683168-25-005753
Q1 2026Quarterly · 2025-06-30GeographyLatin America564,000USD0001683168-25-005753
Q1 2026Quarterly · 2025-06-30GeographyRest of World316,000USD0001683168-25-005753
Q1 2026Quarterly · 2025-06-30GeographyUnited States1,005,000USD0001683168-25-005753
Q4 2025Quarterly · 2025-03-31GeographyAsia485,000USDLegacy provider
Q4 2025Quarterly · 2025-03-31GeographyEurope1,472,000USDLegacy provider
Q4 2025Quarterly · 2025-03-31GeographyLatin America788,000USDLegacy provider
Q4 2025Quarterly · 2025-03-31GeographyRest of World329,000USDLegacy provider
Q4 2025Quarterly · 2025-03-31GeographyUnited States680,000USDLegacy provider
FY 2025Yearly · 2025-03-31GeographyAsia2,317,000USD0001683168-26-004871
FY 2025Yearly · 2025-03-31GeographyEurope5,523,000USD0001683168-26-004871
FY 2025Yearly · 2025-03-31GeographyLatin America2,962,000USD0001683168-26-004871
FY 2025Yearly · 2025-03-31GeographyRest of World875,000USD0001683168-26-004871
FY 2025Yearly · 2025-03-31GeographyUnited States2,611,000USD0001683168-26-004871
FY 2025Yearly · 2025-03-31ProductOther538,000USD0001683168-25-004546
FY 2025Yearly · 2025-03-31ProductProduct13,732,000USD0001683168-25-004546
FY 2025Yearly · 2025-03-31ProductShipping And Handling18,000USD0001683168-25-004546
Q3 2025Quarterly · 2024-12-31GeographyAsia579,000USD0001683168-26-000889
Q3 2025Quarterly · 2024-12-31GeographyEurope1,257,000USD0001683168-26-000889
Q3 2025Quarterly · 2024-12-31GeographyLatin America829,000USD0001683168-26-000889
Q3 2025Quarterly · 2024-12-31GeographyRest of World285,000USD0001683168-26-000889
Q3 2025Quarterly · 2024-12-31GeographyUnited States614,000USD0001683168-26-000889
Q2 2025Quarterly · 2024-09-30GeographyAsia776,000USD0001683168-25-007938
Q2 2025Quarterly · 2024-09-30GeographyEurope1,506,000USD0001683168-25-007938
Q2 2025Quarterly · 2024-09-30GeographyLatin America465,000USD0001683168-25-007938
Q2 2025Quarterly · 2024-09-30GeographyRest of World157,000USD0001683168-25-007938
Q2 2025Quarterly · 2024-09-30GeographyUnited States675,000USD0001683168-25-007938
Q1 2025Quarterly · 2024-06-30GeographyAsia477,000USD0001683168-25-005753
Q1 2025Quarterly · 2024-06-30GeographyEurope1,288,000USD0001683168-25-005753
Q1 2025Quarterly · 2024-06-30GeographyLatin America880,000USD0001683168-25-005753
Q1 2025Quarterly · 2024-06-30GeographyRest of World104,000USD0001683168-25-005753
Q1 2025Quarterly · 2024-06-30GeographyUnited States642,000USD0001683168-25-005753
FY 2024Yearly · 2024-03-31GeographyAsia2,298,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31GeographyEurope4,781,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31GeographyLatin America1,726,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31GeographyRest of World872,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31GeographyUnited States3,058,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31ProductOther394,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31ProductProduct12,313,000USD0001683168-25-004546
FY 2024Yearly · 2024-03-31ProductShipping And Handling28,000USD0001683168-25-004546
Q1 2024Quarterly · 2023-06-30ProductProduct3,328,000USD0001683168-23-005508
Q1 2024Quarterly · 2023-06-30ProductServices99,000USD0001683168-23-005508
FY 2023Yearly · 2023-03-31GeographyAsia2,451,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31GeographyEurope4,051,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31GeographyLatin America2,383,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31GeographyRest of World959,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31GeographyUnited States3,428,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31ProductOther1,304,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31ProductProduct11,926,000USD0001683168-24-004275
FY 2023Yearly · 2023-03-31ProductShipping And Handling42,000USD0001683168-24-004275
Q1 2023Quarterly · 2022-06-30ProductProduct2,955,000USD0001683168-23-005508
Q1 2023Quarterly · 2022-06-30ProductServices1,028,000USD0001683168-23-005508
FY 2022Yearly · 2022-03-31ProductProduct12,179,000USD0001683168-23-004323
FY 2022Yearly · 2022-03-31ProductServices449,000USD0001683168-23-004323
FY 2022Yearly · 2022-03-31ProductShipping And Handling52,000USD0001683168-23-004323
FY 2021Yearly · 2021-03-31ProductProduct18,517,000USD0001683168-22-004940
FY 2021Yearly · 2021-03-31ProductServices112,000USD0001683168-22-004940
FY 2021Yearly · 2021-03-31ProductShipping And Handling37,000USD0001683168-22-004940
Q3 2021Quarterly · 2020-12-31ProductAnimal Care1,357,000USD0001683168-21-000580
Q3 2021Quarterly · 2020-12-31ProductHuman Skin Care3,534,000USD0001683168-21-000580
Q3 2021Quarterly · 2020-12-31ProductOther Sales45,000USD0001683168-21-000580
Q2 2021Quarterly · 2020-09-30ProductAnimal Care951,000USD0001683168-20-004049
Q2 2021Quarterly · 2020-09-30ProductHuman Skin Care4,776,000USD0001683168-20-004049
Q2 2021Quarterly · 2020-09-30ProductOther Sales42,000USD0001683168-20-004049
Q1 2021Quarterly · 2020-06-30ProductAnimal Care377,000USD0001683168-20-002761
Q1 2021Quarterly · 2020-06-30ProductHuman Skin Care6,864,000USD0001683168-20-002761
Q1 2021Quarterly · 2020-06-30ProductOther Sales13,000USD0001683168-20-002761
FY 2020Yearly · 2020-03-31ProductProduct17,777,000USD0001683168-21-002977
FY 2020Yearly · 2020-03-31ProductServices151,000USD0001683168-21-002977
FY 2020Yearly · 2020-03-31ProductShipping And Handling57,000USD0001683168-21-002977
Q3 2020Quarterly · 2019-12-31ProductAnimal Care853,000USD0001683168-21-000580
Q3 2020Quarterly · 2019-12-31ProductHuman Skin Care3,528,000USD0001683168-21-000580
Q3 2020Quarterly · 2019-12-31ProductOther Sales14,000USD0001683168-21-000580
Q2 2020Quarterly · 2019-09-30ProductAnimal Care912,000USD0001683168-20-004049
Q2 2020Quarterly · 2019-09-30ProductHuman Skin Care3,801,000USD0001683168-20-004049
Q2 2020Quarterly · 2019-09-30ProductOther Sales14,000USD0001683168-20-004049
Q1 2020Quarterly · 2019-06-30ProductAnimal Care423,000USD0001683168-20-002761
Q1 2020Quarterly · 2019-06-30ProductHuman Skin Care3,962,000USD0001683168-20-002761
Q1 2020Quarterly · 2019-06-30ProductOther Sales0USD0001683168-20-002761

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.